Wharton's Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499

Citations

WEB OF SCIENCE

17
Citations

SCOPUS

18

초록

The aim of this study was to evaluate the therapeutic effects and mechanisms of Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) in an animal model of Duchenne muscular dystrophy (DMD). Mdx mice (3-5 months old) were administered five different doses of WJ-MSCs through their tail veins. A week after injection, grip strength measurements, creatine kinase (CK) assays, immunohistochemistry, and western blots were performed for comparison between healthy mice, mdx control mice, and WJ-MSC-injected mdx mice. WJ-MSCs exerted dose-dependent multisystem therapeutic effects in mdx mice, by decreasing CK, recovering normal behavior, regenerating muscle, and reducing apoptosis and fibrosis in skeletal muscle. We also confirmed that miR-499-5p is significantly downregulated in mdx mice, and that intravenous injection of WJ-MSCs enhanced its expression, leading to anti-fibrotic effects via targeting TGF beta R 1 and 3. Thus, WJ-MSCs may represent novel allogeneic "off-the-shelf" cellular products for the treatment of DMD and possibly other muscle disorders.

키워드

Duchenne muscular dystrophy; microRNA-499-5p; skeletal muscle fibrosis; Wharton's jelly-derived mesenchymal stem cell; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; REGENERATION; INFLAMMATION; TGF-BETA-1; BETA
제목
Wharton's Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499
저자
Park, Sang Eon; Bin Jeong, Jang; Oh, Shin Ji; Kim, Sun Jeong; Kim, Hyeongseop; Choi, Alee; Choi, Suk-joo; Oh, Soo-young; Ha Ryu, Gyu; Lee, Jeehun; Jeon, Hong Bae; Chang, Jong Wook
DOI
10.3390/biomedicines9091089
발행일
2021-09
유형
Article
저널명
Biomedicines
권
9
호
9